Aphria Inc.
DelistedCIK 1733418fmd_1K7P6K4WYYRYYSN4E5T9BMJDBYManufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jun 01, 2017 to May 31, 2020, 3 periods
| Line item | FY2018 | FY2019 | FY2020 |
|---|---|---|---|
| Total revenues | 37 | 237 | 543 |
| Cost of revenue | – | 138 | – |
| Gross profit | 28 | 75 | 192 |
| Research and development | 0 | 1 | 3 |
| Selling, general and administrative | 26 | 93 | 120 |
| Operating income | (12) | (145) | (66) |
| Interest expense | 1 | 8 | 34 |
| Income before taxes | 36 | (16) | (81) |
| Income tax expense | 6 | 1 | 4 |
| Net income from continuing operations | 29 | (16) | (85) |
| Net income | 29 | (16) | (85) |